{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:43:17Z","timestamp":1792478597377,"version":"4.5.0"},"reference-count":63,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15849","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:12:36Z","timestamp":1788783156000},"page":"1-15","source":"Crossref","is-referenced-by-count":0,"title":["KLF2 as a prognostic and potential therapeutic target associated with ferroptosis in serous ovarian cancer: An integrative bioinformatics and clinical validation study"],"prefix":"10.3892","volume":"32","author":[{"given":"Yuanyi","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory, Chengdu Pidu District People's Hospital, Chengdu, Sichuan 611730, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Chengdu Pidu District People's Hospital, Chengdu, Sichuan 611730, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Chengdu Pidu District People's Hospital, Chengdu, Sichuan 611730, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Chengdu Pidu District People's Hospital, Chengdu, Sichuan 611730, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangbo","family":"Lan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Chengdu Pidu District People's Hospital, Chengdu, Sichuan 611730, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youli","family":"Jian","sequence":"additional","affiliation":[{"name":"Department of Pathology, Chengdu Pidu District People's Hospital, Chengdu, Sichuan 611730, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, Chengdu Pidu District People's Hospital, Chengdu, Sichuan 611730, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Chengdu Pidu District People's Hospital, Chengdu, Sichuan 611730, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Chengdu Pidu District People's Hospital, Chengdu, Sichuan 611730, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, Chengdu Pidu District People's Hospital, Chengdu, Sichuan 611730, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, Chengdu Pidu District People's Hospital, Chengdu, Sichuan 611730, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"key20261020093153_b1-ol-32-5-15849","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"key20261020093153_b2-ol-32-5-15849","first-page":"436","article-title":"Transforming treatment paradigms: Focus on personalized medicine for high-grade serous ovarian cancer","volume":"75","author":"Kordowitzki","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"key20261020093153_b3-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1001\/jama.2025.9495","article-title":"Ovarian cancer: A review","volume":"334","author":"Caruso","year":"2025","journal-title":"JAMA"},{"key":"key20261020093153_b4-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/cncr.34582","article-title":"CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An ovarian tumor tissue analysis consortium study","volume":"129","author":"Kang","year":"2023","journal-title":"Cancer"},{"key":"key20261020093153_b5-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"864578","DOI":"10.3389\/fgene.2022.864578","article-title":"MCM10 is a prognostic biomarker and correlated with immune checkpoints in ovarian cancer","volume":"13","author":"Wu","year":"2022","journal-title":"Front Genet"},{"key":"key20261020093153_b6-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1007\/s12672-025-03880-7","article-title":"Single cell transcriptomic analysis reveals molecular mechanisms of chemoresistance and immune microenvironment remodeling in ovarian cancer","volume":"16","author":"Hu","year":"2025","journal-title":"Discov Oncol"},{"key":"key20261020093153_b7-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"146701","DOI":"10.1016\/j.gene.2022.146701","article-title":"Identification of immunity- and ferroptosis-related genes for predicting the prognosis of serous ovarian cancer","volume":"838","author":"Yuan","year":"2022","journal-title":"Gene"},{"key":"key20261020093153_b8-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"807862","DOI":"10.3389\/fcell.2021.807862","article-title":"Integrated analysis of Ferroptosis-related biomarker signatures to improve the diagnosis and prognosis prediction of ovarian cancer","volume":"9","author":"Wang","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"key20261020093153_b9-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00011-022-01672-1","article-title":"Molecular mechanisms of ferroptosis and relevance to inflammation","volume":"72","author":"Deng","year":"2023","journal-title":"Inflamm Res"},{"key":"key20261020093153_b10-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: Opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J Hematol Oncol"},{"key":"key20261020093153_b11-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","article-title":"The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions","volume":"42","author":"Lei","year":"2024","journal-title":"Cancer Cell"},{"key":"key20261020093153_b12-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"key20261020093153_b13-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20261020093153_b14-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.tips.2023.06.005","article-title":"Ferroptosis of immune cells in the tumor microenvironment","volume":"44","author":"Kim","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"key20261020093153_b15-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/s41568-025-00864-1","article-title":"Decoding ferroptosis for cancer therapy","volume":"25","author":"Wahida","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"key20261020093153_b16-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"key20261020093153_b17-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"BSR20200219","DOI":"10.1042\/BSR20200219","article-title":"Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases","volume":"40","author":"Ndiaye","year":"2020","journal-title":"Biosci Rep"},{"key":"key20261020093153_b18-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41420-025-02716-1","article-title":"Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancer","volume":"11","author":"Cerra","year":"2025","journal-title":"Cell Death Discov"},{"key":"key20261020093153_b19-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"778557","DOI":"10.3389\/fonc.2021.778557","article-title":"The Ferroptosis-related noncoding RNA signature as a novel prognostic biomarker in the tumor microenvironment, immunotherapy, and drug screening of gastric adenocarcinoma","volume":"11","author":"Chen","year":"2021","journal-title":"Front Oncol"},{"key":"key20261020093153_b20-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"992044","DOI":"10.3389\/fmolb.2022.992044","article-title":"Identification and verification of ferroptosis-related genes in the synovial tissue of osteoarthritis using bioinformatics analysis","volume":"9","author":"Xia","year":"2022","journal-title":"Front Mol Biosci"},{"key":"key20261020093153_b21-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"key20261020093153_b22-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ijgo.12614","article-title":"Cancer of the ovary, fallopian tube, and peritoneum","volume":"2","author":"Berek","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"key20261020093153_b23-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"16951","DOI":"10.18632\/oncotarget.15208","article-title":"ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells","volume":"8","author":"Yeung","year":"2017","journal-title":"Oncotarget"},{"key":"key20261020093153_b24-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: An R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"key20261020093153_b25-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: An open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"key20261020093153_b26-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20261020093153_b27-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"key20261020093153_b28-ol-32-5-15849","article-title":"Human Protein Atlas. v24.proteinatlas.org"},{"key":"key20261020093153_b29-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: Gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"key20261020093153_b30-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"key20261020093153_b31-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cstres.2025.02.001","article-title":"Increased intracellular stress responses and decreased KLF2 in adult patients with atopic dermatitis","volume":"30","author":"Sugiura","year":"2025","journal-title":"Cell Stress Chaperones"},{"key":"key20261020093153_b32-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3390\/ijms20040952","article-title":"High-Grade serous ovarian cancer: Basic sciences, clinical and therapeutic standpoints","volume":"20","author":"Lisio","year":"2019","journal-title":"Int J Mol Sci"},{"key":"key20261020093153_b33-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.semcancer.2017.04.009","article-title":"Ovarian cancer stem cells more questions than answers","volume":"44","author":"Ottevanger","year":"2017","journal-title":"Semin Cancer Biol"},{"key":"key20261020093153_b34-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer: Pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease\u2020","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann Oncol"},{"key":"key20261020093153_b35-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1136\/ijgc-2024-005305","article-title":"Molecular changes driving low-grade serous ovarian cancer and implications for treatment","volume":"34","author":"Kelliher","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"key20261020093153_b36-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41419-025-08189-5","article-title":"Photodynamic therapy simultaneously induces ferroptosis- and apoptosis-like lipid signatures in ovarian cancer cells","volume":"16","author":"Overchuk","year":"2025","journal-title":"Cell Death Dis"},{"key":"key20261020093153_b37-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1002\/1878-0261.70067","article-title":"Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer","volume":"19","author":"Glossner","year":"2025","journal-title":"Mol Oncol"},{"key":"key20261020093153_b38-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s11658-021-00287-4","article-title":"Primary high-grade serous ovarian cancer cells are sensitive to senescence induced by carboplatin and paclitaxel in vitro","volume":"26","author":"Uruski","year":"2021","journal-title":"Cell Mol Biol Lett"},{"key":"key20261020093153_b39-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/1878-0261.13768","article-title":"Plasma-activated media selectively induces apoptotic death via an orchestrated oxidative stress pathway in high-grade serous ovarian cancer cells","volume":"19","author":"Davies","year":"2025","journal-title":"Mol Oncol"},{"key":"key20261020093153_b40-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/s41419-023-05778-0","article-title":"Butyrate dictates ferroptosis sensitivity through FFAR2-mTOR signaling","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis"},{"key":"key20261020093153_b41-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"1611564","DOI":"10.3389\/fped.2025.1611564","article-title":"MFAP4 as a novel biomarker for predicting liver fibrosis and prognosis in infants with biliary atresia through the integration of bioinformatics with clinical data analysis","volume":"13","author":"Yang","year":"2025","journal-title":"Front Pediatr"},{"key":"key20261020093153_b42-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"102812","DOI":"10.1016\/j.omtn.2025.102812","article-title":"cncFinder: A graph-attention-network-based interpretable learning model to identify bifunctional long non-coding RNAs","volume":"37","author":"Tang","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"key":"key20261020093153_b43-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"156892","DOI":"10.1016\/j.phymed.2025.156892","article-title":"Predicting the molecular mechanism of ginger targeting PRMT1\/BTG2 axis to inhibit gastric cancer based on WGCNA and machine algorithms","volume":"143","author":"Chen","year":"2025","journal-title":"Phytomedicine"},{"key":"key20261020093153_b44-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2015.03.020","article-title":"Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer","volume":"362","author":"Onstenk","year":"2015","journal-title":"Cancer Lett"},{"key":"key20261020093153_b45-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3892\/or.2025.8967","article-title":"Comprehensive genetic profiling using tissue and blood in locally advanced tumors","volume":"54","author":"Fujiyoshi","year":"2025","journal-title":"Oncol Rep"},{"key":"key20261020093153_b46-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"101631","DOI":"10.1016\/j.xcrm.2024.101631","article-title":"Genomic profiling of a multi-lineage and multi-passage patient-derived xenograft biobank reflects heterogeneity of ovarian cancer","volume":"5","author":"Qin","year":"2024","journal-title":"Cell Rep Med"},{"key":"key20261020093153_b47-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/oncolo\/oyae162","article-title":"Why is a small sample size not enough?","volume":"29","author":"Cao","year":"2024","journal-title":"Oncologist"},{"key":"key20261020093153_b48-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.3390\/ijms18112383","article-title":"KLF2 in regulation of NF-\u03baB-Mediated immune cell function and inflammation","volume":"18","author":"Jha","year":"2017","journal-title":"Int J Mol Sci"},{"key":"key20261020093153_b49-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41417-017-0007-9","article-title":"Long non-coding RNA DLEU1 predicts poor prognosis of gastric cancer and contributes to cell proliferation by epigenetically suppressing KLF2","volume":"25","author":"Li","year":"2018","journal-title":"Cancer Gene Ther"},{"key":"key20261020093153_b50-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.09.014","article-title":"KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma","volume":"522","author":"Lu","year":"2021","journal-title":"Cancer Lett"},{"key":"key20261020093153_b51-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/cjp2.325","article-title":"KLF2 inhibits colorectal cancer progression and metastasis by inducing ferroptosis via the PI3K\/AKT signaling pathway","volume":"9","author":"Li","year":"2023","journal-title":"J Pathol Clin Res"},{"key":"key20261020093153_b52-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"1182123","DOI":"10.3389\/fcell.2023.1182123","article-title":"KLF2 is a clinical diagnostic and treatment biomarker of breast cancer","volume":"11","author":"Li","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"key20261020093153_b53-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1038\/sj.onc.1208546","article-title":"Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis","volume":"224","author":"Wang","year":"2005","journal-title":"Oncogene"},{"key":"key20261020093153_b54-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/1471-2164-14-508","article-title":"An IL6-correlated signature in serous epithelial ovarian cancer associates with growth factor response","volume":"14","author":"Pinciroli","year":"2013","journal-title":"BMC Genomics"},{"key":"key20261020093153_b55-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr Biol"},{"key":"key20261020093153_b56-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.immuni.2020.06.016","article-title":"An oncogenic alteration creates a microenvironment that promotes tumor progression by conferring a metabolic advantage to regulatory T cells","volume":"53","author":"Kumagai","year":"2020","journal-title":"Immunity"},{"key":"key20261020093153_b57-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1134\/S0006297920010058","article-title":"Transcription factor KLF2 and its role in the regulation of inflammatory processes","volume":"85","author":"Turpaev","year":"2020","journal-title":"Biochemistry (Mosc)"},{"key":"key20261020093153_b58-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"e70015","DOI":"10.1002\/ddr.70015","article-title":"KLF2 inhibits ferroptosis and improves mitochondrial dysfunction in chondrocyte through SIRT1\/GPX4 signaling to improve osteoarthritis","volume":"85","author":"Shi","year":"2024","journal-title":"Drug Dev Res"},{"key":"key20261020093153_b59-ol-32-5-15849","first-page":"1333","article-title":"miR-92a-3p promotes the proliferation and invasion of gastric cancer cells by targeting KLF2","volume":"34","author":"Mao","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"key":"key20261020093153_b60-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.7150\/jca.92379","article-title":"MiR-15b-3p weakens bicalutamide sensitivity in prostate cancer via targeting KLF2 to suppress ferroptosis","volume":"15","author":"Zhang","year":"2024","journal-title":"J Cancer"},{"key":"key20261020093153_b61-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.job.2023.08.006","article-title":"Simvastatin inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma through KLF2 signal","volume":"65","author":"Kou","year":"2023","journal-title":"J Oral Biosci"},{"key":"key20261020093153_b62-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"8336070","DOI":"10.1155\/2022\/8336070","article-title":"Simvastatin inhibits NLRP3 inflammasome activation and ameliorates lung injury in Hyperoxia-induced bronchopulmonary dysplasia via the KLF2-Mediated mechanism","volume":"25","author":"Wang","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"key20261020093153_b63-ol-32-5-15849","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.bbagen.2015.03.011","article-title":"Endothelial protective genes induced by statin are mimicked by ERK5 activation as triggered by a drug combination of FTI-277 and GGTI-298","volume":"1850","author":"Chu","year":"2015","journal-title":"Biochim Biophys Acta"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:31:59Z","timestamp":1792477919000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":63,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9,7]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15849","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]}}}